GLP-1类药物,如Ozempic和Wegovy,使病人减肥和改善健康至少持续一年。 GLP-1 drugs like Ozempic and Wegovy keep patients losing weight and improving health for at least a year.

一项新的研究发现,象Ozempic和Wegovy这样的GLP-1减重药物至少保持其效力一年,参与者持续大量减重,代谢健康得到改善。 A new study finds that GLP-1 weight-loss drugs like Ozempic and Wegovy maintain their effectiveness for at least one year, with participants sustaining significant weight loss and improved metabolic health. 研究人员指出,继续坚持改变药物和生活方式有助于取得持久结果,尽管两年之后的长期结果仍在调查之中。 Researchers note continued adherence to medication and lifestyle changes contributed to lasting results, though long-term outcomes beyond two years remain under investigation.